Life Sciences, Journal Year: 2024, Volume and Issue: 355, P. 122987 - 122987
Published: Aug. 14, 2024
Language: Английский
Life Sciences, Journal Year: 2024, Volume and Issue: 355, P. 122987 - 122987
Published: Aug. 14, 2024
Language: Английский
Cellular and Molecular Immunology, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 27, 2025
Language: Английский
Citations
0Genes, Journal Year: 2025, Volume and Issue: 16(3), P. 330 - 330
Published: March 12, 2025
Extracellular vesicles (EVs) are nanovesicles that facilitate intercellular communication by carrying essential biomolecules under physiological and pathological conditions including microRNAs (miRNAs). They found in various body fluids, such as blood, urine, saliva, their levels fluctuate with disease progression, making them valuable diagnostic tools. However, isolating EVs is challenging due to small size biological complexity. Here, we summarize the principles behind most common EV isolation methods ultracentrifugation, precipitation, immunoaffinity, sorting, ultrafiltration, exclusion chromatography, microfluidics while highlighting protocol strengths weaknesses. We also review main strategies identify quantify circulating miRNAs a particular focus on EV-encapsulated miRNAs. Since these hold special clinical interest derived from superior stability therapeutic potential, information provided here should provide guidance for future research initiatives promising field of treatment based
Language: Английский
Citations
0Journal of Extracellular Vesicles, Journal Year: 2024, Volume and Issue: 13(12)
Published: Dec. 1, 2024
Abstract T‐cell haematological malignancies progress rapidly and have a high mortality rate effective treatments are still lacking. Here, we developed drug delivery system utilizing 293T cell‐derived extracellular vesicles (EVs) modified with an anti‐CD7 single‐chain variable fragment (αCD7/EVs). Given the challenges of chemotherapy resistance in patients malignancy, selected cytochrome C (CytC) Bcl2 siRNA ( siBcl2 ) as therapeutic agents loaded them into αCD7/EVs (αCD7/EVs/CytC/ ). We found that efficiently targeted were internalized by human T‐ALL Molt‐4 cells. In addition, interaction between αCD7 CD7 switched EV entry pathway cells from macropinocytosis‐dependent endocytosis to clathrin‐mediated endocytosis, thereby reducing EV‐lysosome colocalization, ultimately improving CytC efficiency increasing cytotoxicity nascent EVs EV‐treated Notably, αCD7/EVs/CytC/ demonstrated similar efficacy against both chemotherapy‐resistant (CR‐Molt‐4). Furthermore, exhibited safety, low immunogenicity minimal impact on T Therefore, promising approaches for treating + malignancies.
Language: Английский
Citations
1Life Sciences, Journal Year: 2024, Volume and Issue: 355, P. 122987 - 122987
Published: Aug. 14, 2024
Language: Английский
Citations
1